H.R. 2707 · 118th Congress
MADE in America Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CarterSponsor13 cosponsors · 2 D, 11 R
R
Bilirakis
TB
R
Balderson
RC
R
Crawford
MC
D
Cartwright
HG
R
Griffith
RH
R
Hudson
DH
R
Harshbarger
NL
R
Langworthy
CM
R
Miller
DS
D
Soto
JV
R
Van Drew
RJ
R
Jackson
JR
R
Rutherford11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act
What it does: CRS summary · Introduced in House · Apr 19, 2023
Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act
This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products.
Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone.
The bill defines distressed zone as an area that has been designated as a qualified opportunity zone by the Internal Revenue Service (i.e., an economically distressed community in which certain new investments may be eligible for preferential tax treatment) and that has a poverty rate of over 30%.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: MADE in America Act
Also known as: Manufacturing API, Drugs, and Excipients in America Act
Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Apr 19, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.